Copyright Reports & Markets. All rights reserved.

Global Prostate Specific Antigen (PSA) Testing Market Opportunities and Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Prostate Specific Antigen (PSA) Testing Market Status and Forecast (2017-2028)
      • 1.3.2 Global Prostate Specific Antigen (PSA) Testing Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Prostate Specific Antigen (PSA) Testing Supply by Company

    • 2.1 Global Prostate Specific Antigen (PSA) Testing Sales Value by Company
    • 2.2 Prostate Specific Antigen (PSA) Testing Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Prostate Specific Antigen (PSA) Testing Market Status by Type

    • 3.1 Prostate Specific Antigen (PSA) Testing Type Introduction
      • 3.1.1 Radioimmunoassay
      • 3.1.2 Enzyme Immunoassay
    • 3.2 Global Prostate Specific Antigen (PSA) Testing Market by Type
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Prostate Specific Antigen (PSA) Testing Market Status by Application

    • 4.1 Prostate Specific Antigen (PSA) Testing Segment by Application
      • 4.1.1 Hospitals
      • 4.1.2 Clinics
      • 4.1.3 Diagnostic Centers
      • 4.1.4 Research Institute
      • 4.1.5 Others
    • 4.2 Global Prostate Specific Antigen (PSA) Testing Market by Application
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Prostate Specific Antigen (PSA) Testing Market Status by Region

    • 5.1 Global Prostate Specific Antigen (PSA) Testing Market by Region
    • 5.2 North America Prostate Specific Antigen (PSA) Testing Market Status
    • 5.3 Europe Prostate Specific Antigen (PSA) Testing Market Status
    • 5.4 Asia Pacific Prostate Specific Antigen (PSA) Testing Market Status
    • 5.5 Central & South America Prostate Specific Antigen (PSA) Testing Market Status
    • 5.6 Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Status

    6 North America Prostate Specific Antigen (PSA) Testing Market Status

    • 6.1 North America Prostate Specific Antigen (PSA) Testing Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Prostate Specific Antigen (PSA) Testing Market Status

    • 7.1 Europe Prostate Specific Antigen (PSA) Testing Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Prostate Specific Antigen (PSA) Testing Market Status

    • 8.1 Asia Pacific Prostate Specific Antigen (PSA) Testing Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Prostate Specific Antigen (PSA) Testing Market Status

    • 9.1 Central & South America Prostate Specific Antigen (PSA) Testing Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Status

    • 10.1 Middle East & Africa Prostate Specific Antigen (PSA) Testing Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global Prostate Specific Antigen (PSA) Testing Market Forecast by Type and by Application

    • 12.1 Global Prostate Specific Antigen (PSA) Testing Sales Value Forecast (2023-2028)
    • 12.2 Global Prostate Specific Antigen (PSA) Testing Forecast by Type
    • 12.3 Global Prostate Specific Antigen (PSA) Testing Forecast by Application

    13 Global Prostate Specific Antigen (PSA) Testing Market Forecast by Region/Country

    • 13.1 Global Prostate Specific Antigen (PSA) Testing Market Forecast by Region (2023-2028)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Siemens Healthineers
      • 14.1.1 Company Information
      • 14.1.2 Prostate Specific Antigen (PSA) Testing Product Introduction
      • 14.1.3 Siemens Healthineers Prostate Specific Antigen (PSA) Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.1.4 SWOT Analysis
    • 14.2 Roche Holding AG
      • 14.2.1 Company Information
      • 14.2.2 Prostate Specific Antigen (PSA) Testing Product Introduction
      • 14.2.3 Roche Holding AG Prostate Specific Antigen (PSA) Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.2.4 SWOT Analysis
    • 14.3 Ortho Clinical
      • 14.3.1 Company Information
      • 14.3.2 Prostate Specific Antigen (PSA) Testing Product Introduction
      • 14.3.3 Ortho Clinical Prostate Specific Antigen (PSA) Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.3.4 SWOT Analysis
    • 14.4 Merck
      • 14.4.1 Company Information
      • 14.4.2 Prostate Specific Antigen (PSA) Testing Product Introduction
      • 14.4.3 Merck Prostate Specific Antigen (PSA) Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.4.4 SWOT Analysis
    • 14.5 Mediwatch(LABORIE)
      • 14.5.1 Company Information
      • 14.5.2 Prostate Specific Antigen (PSA) Testing Product Introduction
      • 14.5.3 Mediwatch(LABORIE) Prostate Specific Antigen (PSA) Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.5.4 SWOT Analysis
    • 14.6 GlaxoSmith Kline
      • 14.6.1 Company Information
      • 14.6.2 Prostate Specific Antigen (PSA) Testing Product Introduction
      • 14.6.3 GlaxoSmith Kline Prostate Specific Antigen (PSA) Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.6.4 SWOT Analysis
    • 14.7 GE Healthcare
      • 14.7.1 Company Information
      • 14.7.2 Prostate Specific Antigen (PSA) Testing Product Introduction
      • 14.7.3 GE Healthcare Prostate Specific Antigen (PSA) Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.7.4 SWOT Analysis
    • 14.8 Fujirebio
      • 14.8.1 Company Information
      • 14.8.2 Prostate Specific Antigen (PSA) Testing Product Introduction
      • 14.8.3 Fujirebio Prostate Specific Antigen (PSA) Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.8.4 SWOT Analysis
    • 14.9 Endocare
      • 14.9.1 Company Information
      • 14.9.2 Prostate Specific Antigen (PSA) Testing Product Introduction
      • 14.9.3 Endocare Prostate Specific Antigen (PSA) Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.9.4 SWOT Analysis
    • 14.10 DiaSorin
      • 14.10.1 Company Information
      • 14.10.2 Prostate Specific Antigen (PSA) Testing Product Introduction
      • 14.10.3 DiaSorin Prostate Specific Antigen (PSA) Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.10.4 SWOT Analysis
    • 14.11 Cleveland Diagnostics
    • 14.12 Bristol Myers Squibb
    • 14.13 Boditech
    • 14.14 Beckman Coulter
    • 14.15 Anixa Biosciences
    • 14.16 Abbott

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global Prostate Specific Antigen (PSA) Testing market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Prostate Specific Antigen (PSA) Testing industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to GRD Survey, the global Prostate Specific Antigen (PSA) Testing market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Prostate Specific Antigen (PSA) Testing Market Opportunities and Forecast 2023-2028 report makes a brilliant attempt to unveil key opportunities available in the global Prostate Specific Antigen (PSA) Testing market under the Covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global Prostate Specific Antigen (PSA) Testing Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global Prostate Specific Antigen (PSA) Testing industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      Radioimmunoassay
      Enzyme Immunoassay

      Segmented by Application
      Hospitals
      Clinics
      Diagnostic Centers
      Research Institute
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Siemens Healthineers
      Roche Holding AG
      Ortho Clinical
      Merck
      Mediwatch(LABORIE)
      GlaxoSmith Kline
      GE Healthcare
      Fujirebio
      Endocare
      DiaSorin
      Cleveland Diagnostics
      Bristol Myers Squibb
      Boditech
      Beckman Coulter
      Anixa Biosciences
      Abbott
      Buy now